With the American Association for Cancer Research’s annual conference now underway, oncology researchers can expect ...

Boehringer Ingelheim unveiled new data from its top oncology prospect zongertinib, further backing the drug’s prowess in ...

A new survey shows animal owners deeply appreciate veterinarians, but challenges like work-life balance and emotional strain remain widely misunderstood.

Boehringer Ingelheim reported new and updated data from the Beamion LUNG-1 trial evaluating zongertinib in previously treated patients with HER2 (ERBB2)-mutant advanced non-small cell lung cancer ...

Zongertinib, an oral therapy shown to have strong responses in patients previously treated for HER2 -mutated non–small cell ...

The HER2-targeted therapy zongertinib demonstrated clinical benefits for previously treated patients with advanced ...

Zongertinib elicited meaningful results in previously treated patients with HER2-mutated, advanced non–small cell lung cancer ...

The HER2-targeted therapy zongertinib demonstrated clinical benefits for previously treated patients with advanced HER2-mutant non-small cell lung cancer – particularly those with specific HER2 ...

Prime IV Hydration & Wellness, the nation's leading IV drip therapy franchise, is proud to announce several prestigious award wins in just the first few months of 2025 that highlight the brand's ...

Kessler Foundation, known for its work in disability rehabilitation research, has earned national recognition as one of the Best Nonprofits to Work For. This marks the third consecutive year and the ...